Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 351 - 400 out of 14,060

Document Document Title
WO/2013/040068
The presently disclosed subject matter provides methods of preparing synthetic prostacyclin analogues, including Beraprost, either as racemic mixtures or as single stereoisomers. Also provided are novel synthetic intermediates for use in...  
WO/2013/039221
An aromatic amine derivative represented by general formula (1). In general formula (1), R1 to R10 each independently are a hydrogen atom or substituent group. In general formula (1), R1 is represented by general formula (2), and any one...  
WO/2013/038430
Disclosed herein is 10-α/β-D-Arabinofuranosylundecenes of general Formula (II) or pharmaceutically acceptable salts thereof as anti-mycobacterial agents in vitro; (II) wherein R, R1 and R" are as defined herein in the specification. Th...  
WO/2013/038931
This method of cheaply and easily producing a 2-oxo-2H-cyclohepta[b]furan analogue useful as a pharmaceutical intermediate with high purity and high yields. In this method, a 2-oxo-2H-cyclohepta[b]furan analogue represented by general fo...  
WO/2013/038650
A compound represented by formula (1). (In the formula, A1 represents O, S, Si(Ar1)(Ar2), P(=O)(Ar3)(Ar4), a substituted or unsubstituted arylene group having 6 to 30 ring-forming carbon atoms, or a substituted or unsubstituted heteroary...  
WO/2013/033971
The present invention relates to compounds of formula (I) that are useful as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, ...  
WO/2013/034048
The present invention relates to compounds of formula (I) that are useful as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, ...  
WO/2013/033899
The present invention relates to compounds of formula (I) that are useful as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, ...  
WO/2013/033058
A process is provided for carrying out an oxidation on a sprayable feed including a furanic substrate to be oxidized and a catalytically effective combination of cobalt, manganese, and bromide components for catalyzing the oxidation of t...  
WO/2013/029479
Disclosed in the present invention is a mycophenolic acid derivative shown by the following general formula (V) and the pharmaceutically acceptable salts thereof, wherein L1 is -O-R2, -QCOOR2 or -QCONR2R3, Q is C1~C10. Alkylidene or C1~C...  
WO/2013/033081
A process is provided for carrying out an oxidation on a feed including levulinic acid and/or a levulinic acid oxidation precursor to succinic acid, one or more furanic oxidation precursors of 2,5-furandicarboxylic acid and a catalytical...  
WO/2013/029555
Provided are lavendustin A derivatives, a preparation method and use thereof. The compounds are shown by the structure of formula (I), wherein R is alkyl, ether group, carbonyl, p-tolyl, five-membered heterocyclic group, five-membered su...  
WO/2013/030131
The invention relates to a method for producing furfural by reacting pentose in water and in the presence of carboxylic acid and a heterogeneous acid catalyst, said method being carried out in an aqueous solution of carboxylic acid as th...  
WO/2013/033081
A process is provided for carrying out an oxidation on a feed including levulinic acid and/or a levulinic acid oxidation precursor to succinic acid, one or more furanic oxidation precursors of 2,5-furandicarboxylic acid and a catalytical...  
WO/2013/030193
The present invention relates to γ,δ-unsaturated a-amino acids of general formula (I). The present invention also provides a versatile process for the stereospecific synthesis of said compounds of formula (I), involving a Wittig reacti...  
WO/2013/026392
A 3-(α-methoxyl) methylene benzofuran-2(3H)-ketone synthesis method comprises the synthesis of O-hydroxy phenylacetic acid, the synthesis of lactone and the synthesis of an end product, with focus on lactone synthesis improvement, such ...  
WO/2013/026726
The present invention provides compounds of formula I wherein Q is Q1 or Q2; A1, A2, A3 and A4 are independently of each other C-H, C-R7, or nitrogen; R1 is C1-C8haloalkyl; R2 is aryl or aryl substituted by one to five R11, or heteroaryl...  
WO/2013/028307
This application relates to derivatives of hydrocarbon terpenes (e.g., myrcene or farnesene), to methods of making the derivatives, and to the use of the derivatives as oils, solvents, lubricants, additives or base oils for lubricant com...  
WO/2013/026455
The present invention provides compounds comprising a substructure of below formula 3: or a salt or prodrug thereof and the use of such compounds in treatment of e.g. CNS disorders.  
WO/2013/026737
The invention relates to a method for producing γ-hydroxycarboxylic esters and γ-lactones, which are suitable as aromatic substances, by electrochemical reductive cross-coupling of α,β-unsaturated esters with carbonyl compounds in an...  
WO/2013/027774
The purpose of the present invention is, in the production of produce gamma-butyrolactone by the dehydrogenation reaction of 1,4-butanediol in the presence of a catalyst, to produce gamma-butyrolactone with high efficiency by preventing ...  
WO/2013/027694
The purpose of the present invention is to provide a near infrared light-emitting compound which has an ability to highly specifically binding to Aβ, a high permeability through the blood-brain barrier, an ability to quickly disappear f...  
WO/2013/026724
The present invention relates to compounds of formula (IA) wherein QA is QA1 or QA2 P is P1, heterocyclyl or heterocyclyl substituted by one to five Z; and wherein A1, A2, A3, A4, G1, Z, R1, R2, R3 and R4 are as defined in claim 1; or a ...  
WO/2013/028289
Described herein are oxygen scavengers, oxygen scavenging polymeric compositions, and oxygen scavenging articles. The polymeric compositions comprising the oxygen scavengers may have utility in packaging, sealing, wrapping, and storing o...  
WO/2013/026737
The invention relates to a method for producing γ-hydroxycarboxylic esters and γ-lactones, which are suitable as aromatic substances, by electrochemical reductive cross-coupling of α,β-unsaturated esters with carbonyl compounds in an...  
WO/2013/025564
Furfural is produced from a xylan-containing lignocellulosic feedstock which is contacted with water in the presence of an acid catalyst. Specifically, the catalyst is sulfuric acid characterized by a room temperature pH in the range of ...  
WO/2013/024730
This organic electroluminescent element, which uses a compound represented by the belowmentioned general formula, emits dark blue light and has a low change in chromaticity and a low change in driving voltage after long-term driving. (R1...  
WO/2013/024162
This invention relates to an efficient procedure for purifying HMF by crystallization at low temperature from an organic solvent.  
WO/2013/024898
The primary purpose of the present invention is to provide a novel heterocyclic derivative or a pharmaceutically acceptable salt thereof. Examples of the present invention can include a heterocyclic compound represented by general formul...  
WO/2013/025733
Compounds, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds to treat, prevent or diagnose diseases, disorders, or conditions associated with one ...  
WO/2013/024493
This invention relates to diterpenes of general formula (1) belonging to labdane class, isolated from Leucas stelligera, being useful for prevention, treatment, inhibition or controlling growth and proliferation of mycobacterial activity...  
WO/2013/025564
Furfural is produced from a xylan-containing lignocellulosic feedstock which is contacted with water in the presence of an acid catalyst. Specifically, the catalyst is sulfuric acid characterized by a room temperature pH in the range of ...  
WO/2013/024493
This invention relates to diterpenes of general formula (1) belonging to labdane class, isolated from Leucas stelligera, being useful for prevention, treatment, inhibition or controlling growth and proliferation of mycobacterial activity...  
WO/2013/026024
An energy curable bonding resin composition that prevents corrosion in metallic optical structures including DVDs includes at least one monomer, acrylated epoxidized soya bean oil, and a photoinitiator of among 2,4,6-trimethylbenzoyl-dip...  
WO/2013/023140
Post purification processes and methods for making pure biobased gamma-butyrolactone from renewable carbon resources comprising filtration and/or distillation and/or peroxide treatment are described herein.  
WO/2013/021971
[Problem] To provide an organic photoelectric conversion element whereby conversion efficiency is increased by morphology reformation in a power generation layer, and whereby short-circuit current (Jsc) attenuation when emitting light is...  
WO/2013/023140
Post purification processes and methods for making pure biobased gamma-butyrolactone from renewable carbon resources comprising filtration and/or distillation and/or peroxide treatment are described herein.  
WO/2013/020285
Provided are a method for preparing Antrocin through total chemical synthesis and a use of a composition containing Antrocin or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier in preparing drugs for s...  
WO/2013/018105
A process for extracting vitamins and minerals from a first plant matter(s) is disclosed wherein the said first plant matter(s) is treated with acidic matter followed by extraction with water. Said treatment converts the water-insoluble ...  
WO/2013/017654
Compounds of formula (I) or a pharmaceutically acceptable ester, amide, carbamate or salt thereof, including a salt of such an ester, amide or carbamate in which R1 to R9 have meanings as defined in the Specification, are useful as estro...  
WO/2013/016193
The present invention provides compounds of Formulae (A), (B), (C), and (D), pharmaceutically acceptable salts, solvates, hydrates, polymorphs, co-crystals, tautomers, stereoisomers, isotopically labeled derivatives, and prodrugs thereof...  
WO/2013/014478
The invention relates to a novel process for preparation of dronedarone of formula (I) and pharmaceutically acceptable salts thereof : Formula (I) characterized in that a compound of formula (II) : Formula (II) is aminated with compound ...  
WO/2013/014480
The invention relates to a novel process for preparation of dronedarone of formula (I) and pharmaceutically acceptable salts thereof characterized in that the compound of formula (II) is reduced, and the obtained product is isolated and,...  
WO/2013/014479
The invention relates to a novel process for preparation of dronedarone of formula (I) and pharmaceutically acceptable salts thereof, characterized in that the compound of formula (II) is reacted with dibutylamine of formula (III), under...  
WO/2013/014997
A novel metal salen complex compound having auto-magnetic properties, and a derivative thereof are provided. The present invention is a metal salen complex compound comprising any of the listed compounds.  
WO/2013/014204
The present invention relates to compounds of the formula I, wherein Ht, G, R10, R30, R40, R50 and R60 have the meanings indicated in the claims, which are valuable pharmaceutical active compounds. They are inhibitors of the protease cat...  
WO/2013/014204
The present invention relates to compounds of the formula I, wherein Ht, G, R10, R30, R40, R50 and R60 have the meanings indicated in the claims, which are valuable pharmaceutical active compounds. They are inhibitors of the protease cat...  
WO/2013/016193
The present invention provides compounds of Formulae (A), (B), (C), and (D), pharmaceutically acceptable salts, solvates, hydrates, polymorphs, co-crystals, tautomers, stereoisomers, isotopically labeled derivatives, and prodrugs thereof...  
WO/2013/012590
Methods for forming ammonium salts of C4 diacids in a fermentation process with removal of divalent metal carbonate salts are disclosed. The pH of fermentation broths for production of C4 diacids is controlled by adding alkaline oxygen c...  
WO/2013/011893
Provided are: a novel (meth)acrylate compound which can yield a cured product having a high refractive index and is therefore suitable for optical materials; and a plastic lens obtained using the same. A compound which has a fluorene ske...  

Matches 351 - 400 out of 14,060